Why Biohacking Isn’t a Fad Miami’s high‑performance crowd wants more than an annual physical; they want lab‑grade feedback loops that compress decades of longevity research into weekly habits. Each tool below is grounded in peer‑reviewed evidence and integrated into our Biohacker Starter Package—so you get the upside without the guesswork. 1) Detox Diet (Unprocessed Foods)…
1. From Shortage Boom to Policy Whiplash A national Ozempic®/Wegovy® shortage in 2022–24 opened the floodgates for 503A/503B pharmacies to compound semaglutide. On Feb 21 2025 the FDA formally declared the shortage resolved, citing Novo Nordisk data showing supply now meets or exceeds demand. Because compounding is only permitted when an FDA-approved drug is “not…
1. Why GLP-1s Are Having a Moment Glucagon-like peptide-1 (GLP-1) receptor agonists lower appetite, slow gastric emptying, and boost insulin. Novo Nordisk’s Ozempic®/Wegovy® (semaglutide) mimics GLP-1 alone, while Lilly’s Mounjaro®/Zepbound™ (tirzepatide) hits both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, making it a “dual incretin.” That extra target may explain its headline-grabbing results. (Wikipedia) 2.…
The main distinction between these two medical specialties is patient age and scope of practice. Internal medicine doctors specialize exclusively in adult healthcare (ages 18+), while family medicine physicians treat patients of all ages—from newborns to seniors. Understanding these two specialties’ differences when choosing your primary care provider can help ensure you receive the most…
